Wagner Charles F Jr's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Dec 5, 2025
- Accession no.
- 0000875320-25-000247
- Filed
- Dec 5, 2025
- Trade date
- Dec 3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $6.38M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wagner Charles F JrCIK 0001223348 | Officer (EVP, CO & FO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | Common Stock | SSaleDisposed | −7,000 | $451.00 | −$3,157,000 | 44,725 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −7,000 | $461.00 | −$3,227,000 | 37,725 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.